Avantor (AVTR) Osake Kurssi

Avantor Inc is primarily active in the life sciences and advanced technology industries.

The main competitors of Avantor Inc in the market include Thermo Fisher Scientific, Merck KGaA, and Sigma-Aldrich.

Avantor Inc is a global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries. Founded in 1904 as J.T. Baker Chemical Company, Avantor has a rich history of innovation and expertise in producing high-quality substances for laboratory research and manufacturing processes. Over the years, Avantor has expanded its portfolio, acquiring leading companies such as VWR International in 2017. Today, Avantor is recognized as a trusted partner for scientists, researchers, and manufacturers worldwide, offering a vast range of products, including chemicals, equipment, consumables, and tailored solutions. With a commitment to advancing science and improving lives, Avantor continues to drive innovation and provide essential support to various industries.

Some significant milestones achieved by Avantor Inc include its successful initial public offering in 2018, which raised over $2 billion in capital, allowing the company to strengthen its position in the life sciences and advanced technologies industries. Furthermore, Avantor expanded its global presence through strategic acquisitions, such as the acquisition of VWR Corporation in 2017, which greatly expanded its product and service offerings. Avantor's commitment to innovation led to the development of new solutions and technologies, including the launch of its Raman spectroscopy system. With these achievements, Avantor Inc has solidified its reputation as a leading provider of high-quality products and services to customers worldwide.

Avantor Inc is primarily present in various countries and regions across the globe. With a strong global footprint, the company operates in North America, Europe, Asia-Pacific, and Latin America. Avantor Inc has established a significant presence in countries like the United States, Canada, Germany, France, China, and Brazil, among others. This broad geographical reach enables Avantor Inc to serve diverse markets and deliver its innovative products and solutions to customers worldwide.

Avantor Inc represents a strong set of values and a positive corporate philosophy. The company believes in fostering innovation, driving customer success, and maintaining the highest level of integrity in all business practices. Avantor is committed to providing high-quality products and services that meet customer needs effectively. With a focus on sustainability, Avantor strives to make a positive impact on the environment and communities it operates in. By prioritizing collaboration, teamwork, and diversity, Avantor ensures a supportive and inclusive workplace for its employees. These values and corporate philosophy guide Avantor in delivering exceptional solutions and contributing to the overall success of its stakeholders.

Analyytikot asettavat tällä hetkellä Avantor-osakkeelle keskimääräisen tavoitehinnan 10,78 USD (mediaani: 10,50 USD), mikä merkitsee −29,3 % viimeisimpään hintaan verrattuna. Konsensus perustuu 25 analyytikkoarvioon.

Avantor Analyytikkojen kursstavoitteet 2026

25 analyytikkoa arvioi tällä hetkellä Avantor-osaketta: 8 suosittaa ostoa, 16 pitoa ja 1 myyntiä. Vuodelle 2026 analyytikot odottavat Avantor-yhtiöltä 6,59 Mrd. USD liikevaihtoa ja 0,82 USD osakekohtaista tulosta.

Avantor Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla Avantor-osake noteerataan hintaan 13,38 EUR (15,25 USD).

Avantor-osake (AVTR) on listattuna 6 pörssissä, muun muassa: NYSE (AVTR-PA), SIX (Zürich) (AVG.SW), Frankfurt (AVG.F), München (AVG.MU), Düsseldorf (AVG.DU), Wien (AVTR.VI).

Avantor Inc is a diversified American company specializing in providing product solutions and services for customers in the fields of life sciences, pharmaceuticals, healthcare, high technology, and related industries. The company's business model is based on a wide range of products and a strong service offering, allowing it to have a global presence in various industries and markets. The company is divided into three business segments: Life Sciences, Advanced Technology Solutions, and Applied Materials. The Life Sciences segment offers a comprehensive range of products, including laboratory chemicals, consumables, cell and gene therapy products, and bioreactors and systems. These products are used in research facilities, diagnostic laboratories, biopharmaceutical companies, hospitals, and other institutions. The Advanced Technology Solutions segment provides high-quality chemical and microelectronic materials, as well as specialty chemicals and gases for semiconductor production, the electronics industry, and solar cell production. The company also produces and distributes custom chemicals tailored to the specific requirements of customers. The Applied Materials segment offers innovative advancements in material science and a wide range of products and services, including consumables, fermentation processes, bioreactor solutions, liquid distribution systems, dispensing and filling systems, configuration and detection devices, and so on. Avantor is known for its outstanding customer and product portfolio. The company has a strong presence in the United States, Europe, and Asia, operating in over 30 countries. Through acquisitions and partnerships, the company has expanded its presence in various industries. In a short period of time, the company has gained the position of a leading supplier in the life sciences and related industries. From a customer perspective, the company has a strong customer relationship management program based on its industry-leading services. The company strives to pursue a customer-oriented mindset and flexible business strategy to satisfy customer needs. The company also supports customers in technical and scientific matters with tailored solutions. Avantor's business model is designed for high product quality, customer-oriented services, and a strong presence in various industries. The success of the company is based on strong innovation, a wide range of products, strong partnerships, and flexible business strategies. As a leading company in the life sciences and related industries, Avantor is expected to continue growing strongly in the coming years.

odotettu liikevaihto Avantor on 6,59 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Avantor on 554,36 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Avantor:n hinta-voitto-suhde (P/E) on tällä hetkellä 18,69. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Avantor-osakkeen arvostusta.

Avantor:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,57. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Avantor-osakkeen arvostuskennuslukuna.

Avantor:n Eulpool-laatuscore on 3/10.

Avantor:n ISIN on US05352A1007. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Avantor:n WKN on A2PJN6. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Avantor:n ticker on AVTR. Tämä pörssinoteeraus käytetään Avantor-osakkeiden kauppaan pörssissä.

Avantor maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Avantor kuuluu sektoriin 'Terveydenhuolto'.

Avantor:n osingot jaetaan valuutassa USD.